Press "Enter" to skip to content

Expert Highlights Emerging Agents for Metastatic HER2+ Breast Cancer – Targeted Oncology

admin 0

Expert Highlights Emerging Agents for Metastatic HER2+ Breast Cancer  Targeted Oncology

In an interview with Targeted Oncology, Charles Geyer, MD, discussed the potential role of neratinib as well as other new agents that are coming down the …

“breast cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *